APO Research
Talk to an analyst

APO RESEARCH · REPORT

Satralizumab

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Satralizumab Market Analysis and Forecast 2026-2032

30 December 2025199 pages

Choose your research edition.

Industry ResearchSatralizumab Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Satralizumab Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Satralizumab Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Satralizumab Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Satralizumab Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Satralizumab market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Satralizumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Satralizumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Satralizumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Satralizumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Satralizumab include Hoffmann La Roche, Genentech Inc. and CHUGAI PHARMACEUTICAL CO.,LTD., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Satralizumab, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Satralizumab, also provides the sales of main regions and countries. Of the upcoming market potential for Satralizumab, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Satralizumab sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Satralizumab market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Satralizumab sales, projected growth trends, production technology, application and end-user industry.

Satralizumab Segment by Company

Hoffmann La Roche

Genentech Inc.

CHUGAI PHARMACEUTICAL CO.,LTD.

Satralizumab Segment by Type

Solution

Injection

Satralizumab Segment by Application

Treating Neuromyelitis Optica

Prevention of Neuromyelitis Optica

Others

Satralizumab Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Satralizumab market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Satralizumab and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Satralizumab.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Satralizumab in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Satralizumab manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Satralizumab sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Satralizumab Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Solution Major Manufacturers Table 3. Injection Major Manufacturers Table 4. Global Satralizumab Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Treating Neuromyelitis Optica Major Manufacturers Table 6. Prevention of Neuromyelitis Optica Major Manufacturers Table 7. Others Major Manufacturers Table 8. Satralizumab Industry Trends Table 9. Satralizumab Industry Drivers Table 10. Satralizumab Industry Opportunities and Challenges Table 11. Satralizumab Industry Restraints Table 12. Global Satralizumab Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Satralizumab Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Satralizumab Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Satralizumab Revenue Market Share by Region (2021-2026) Table 16. Global Satralizumab Revenue Market Share by Region (2027-2032) Table 17. Global Satralizumab Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Satralizumab Sales by Region (2021-2026) & (K Units) Table 19. Global Satralizumab Sales by Region (2027-2032) & (K Units) Table 20. Global Satralizumab Sales Market Share by Region (2021-2026) Table 21. Global Satralizumab Sales Market Share by Region (2027-2032) Table 22. Global Satralizumab Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Satralizumab Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Satralizumab Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Satralizumab Sales Market Share by Manufacturers (2021-2026) Table 26. Global Satralizumab Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Satralizumab Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Satralizumab Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Satralizumab Manufacturers, Product Type & Application Table 30. Global Satralizumab Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Satralizumab by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Satralizumab Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Satralizumab Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Satralizumab Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Satralizumab Revenue Market Share by Type (2021-2026) Table 37. Global Satralizumab Revenue Market Share by Type (2027-2032) Table 38. Global Satralizumab Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Satralizumab Sales by Type (2021-2026) & (K Units) Table 40. Global Satralizumab Sales by Type (2027-2032) & (K Units) Table 41. Global Satralizumab Sales Market Share by Type (2021-2026) Table 42. Global Satralizumab Sales Market Share by Type (2027-2032) Table 43. Global Satralizumab Price by Type (2021-2026) & (US$/Unit) Table 44. Global Satralizumab Price by Type (2027-2032) & (US$/Unit) Table 45. Global Satralizumab Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Satralizumab Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Satralizumab Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Satralizumab Revenue Market Share by Application (2021-2026) Table 49. Global Satralizumab Revenue Market Share by Application (2027-2032) Table 50. Global Satralizumab Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Satralizumab Sales by Application (2021-2026) & (K Units) Table 52. Global Satralizumab Sales by Application (2027-2032) & (K Units) Table 53. Global Satralizumab Sales Market Share by Application (2021-2026) Table 54. Global Satralizumab Sales Market Share by Application (2027-2032) Table 55. Global Satralizumab Price by Application (2021-2026) & (US$/Unit) Table 56. Global Satralizumab Price by Application (2027-2032) & (US$/Unit) Table 57. Hoffmann La Roche Company Information Table 58. Hoffmann La Roche Business Overview Table 59. Hoffmann La Roche Satralizumab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Hoffmann La Roche Satralizumab Product Portfolio Table 61. Hoffmann La Roche Recent Development Table 62. Genentech Inc. Company Information Table 63. Genentech Inc. Business Overview Table 64. Genentech Inc. Satralizumab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Genentech Inc. Satralizumab Product Portfolio Table 66. Genentech Inc. Recent Development Table 67. CHUGAI PHARMACEUTICAL CO.,LTD. Company Information Table 68. CHUGAI PHARMACEUTICAL CO.,LTD. Business Overview Table 69. CHUGAI PHARMACEUTICAL CO.,LTD. Satralizumab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. CHUGAI PHARMACEUTICAL CO.,LTD. Satralizumab Product Portfolio Table 71. CHUGAI PHARMACEUTICAL CO.,LTD. Recent Development Table 72. North America Satralizumab Revenue by Type (2021-2026) & (US$ Million) Table 73. North America Satralizumab Revenue by Type (2027-2032) & (US$ Million) Table 74. North America Satralizumab Sales by Type (2021-2026) & (K Units) Table 75. North America Satralizumab Sales by Type (2027-2032) & (K Units) Table 76. North America Satralizumab Sales Price by Type (2021-2026) & (US$/Unit) Table 77. North America Satralizumab Sales Price by Type (2027-2032) & (US$/Unit) Table 78. North America Satralizumab Revenue by Application (2021-2026) & (US$ Million) Table 79. North America Satralizumab Revenue by Application (2027-2032) & (US$ Million) Table 80. North America Satralizumab Sales by Application (2021-2026) & (K Units) Table 81. North America Satralizumab Sales by Application (2027-2032) & (K Units) Table 82. North America Satralizumab Sales Price by Application (2021-2026) & (US$/Unit) Table 83. North America Satralizumab Sales Price by Application (2027-2032) & (US$/Unit) Table 84. North America Satralizumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. North America Satralizumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 86. North America Satralizumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 87. North America Satralizumab Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 88. North America Satralizumab Sales by Country (2021-2026) & (K Units) Table 89. North America Satralizumab Sales by Country (2027-2032) & (K Units) Table 90. North America Satralizumab Sales Price by Country (2021-2026) & (US$/Unit) Table 91. North America Satralizumab Sales Price by Country (2027-2032) & (US$/Unit) Table 92. United States Satralizumab Revenue (2021-2032) & (US$ Million) Table 93. Canada Satralizumab Revenue (2021-2032) & (US$ Million) Table 94. Europe Satralizumab Revenue by Type (2021-2026) & (US$ Million) Table 95. Europe Satralizumab Revenue by Type (2027-2032) & (US$ Million) Table 96. Europe Satralizumab Sales by Type (2021-2026) & (K Units) Table 97. Europe Satralizumab Sales by Type (2027-2032) & (K Units) Table 98. Europe Satralizumab Sales Price by Type (2021-2026) & (US$/Unit) Table 99. Europe Satralizumab Sales Price by Type (2027-2032) & (US$/Unit) Table 100. Europe Satralizumab Revenue by Application (2021-2026) & (US$ Million) Table 101. Europe Satralizumab Revenue by Application (2027-2032) & (US$ Million) Table 102. Europe Satralizumab Sales by Application (2021-2026) & (K Units) Table 103. Europe Satralizumab Sales by Application (2027-2032) & (K Units) Table 104. Europe Satralizumab Sales Price by Application (2021-2026) & (US$/Unit) Table 105. Europe Satralizumab Sales Price by Application (2027-2032) & (US$/Unit) Table 106. Europe Satralizumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Europe Satralizumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 108. Europe Satralizumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 109. Europe Satralizumab Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 110. Europe Satralizumab Sales by Country (2021-2026) & (K Units) Table 111. Europe Satralizumab Sales by Country (2027-2032) & (K Units) Table 112. Europe Satralizumab Sales Price by Country (2021-2026) & (US$/Unit) Table 113. Europe Satralizumab Sales Price by Country (2027-2032) & (US$/Unit) Table 114. Germany Satralizumab Revenue (2021-2032) & (US$ Million) Table 115. France Satralizumab Revenue (2021-2032) & (US$ Million) Table 116. U.K. Satralizumab Revenue (2021-2032) & (US$ Million) Table 117. Italy Satralizumab Revenue (2021-2032) & (US$ Million) Table 118. Netherlands Satralizumab Revenue (2021-2032) & (US$ Million) Table 119. China Satralizumab Revenue by Type (2021-2026) & (US$ Million) Table 120. China Satralizumab Revenue by Type (2027-2032) & (US$ Million) Table 121. China Satralizumab Sales by Type (2021-2026) & (K Units) Table 122. China Satralizumab Sales by Type (2027-2032) & (K Units) Table 123. China Satralizumab Sales Price by Type (2021-2026) & (US$/Unit) Table 124. China Satralizumab Sales Price by Type (2027-2032) & (US$/Unit) Table 125. China Satralizumab Revenue by Application (2021-2026) & (US$ Million) Table 126. China Satralizumab Revenue by Application (2027-2032) & (US$ Million) Table 127. China Satralizumab Sales by Application (2021-2026) & (K Units) Table 128. China Satralizumab Sales by Application (2027-2032) & (K Units) Table 129. China Satralizumab Sales Price by Application (2021-2026) & (US$/Unit) Table 130. China Satralizumab Sales Price by Application (2027-2032) & (US$/Unit) Table 131. Asia Satralizumab Revenue by Type (2021-2026) & (US$ Million) Table 132. Asia Satralizumab Revenue by Type (2027-2032) & (US$ Million) Table 133. Asia Satralizumab Sales by Type (2021-2026) & (K Units) Table 134. Asia Satralizumab Sales by Type (2027-2032) & (K Units) Table 135. Asia Satralizumab Sales Price by Type (2021-2026) & (US$/Unit) Table 136. Asia Satralizumab Sales Price by Type (2027-2032) & (US$/Unit) Table 137. Asia Satralizumab Revenue by Application (2021-2026) & (US$ Million) Table 138. Asia Satralizumab Revenue by Application (2027-2032) & (US$ Million) Table 139. Asia Satralizumab Sales by Application (2021-2026) & (K Units) Table 140. Asia Satralizumab Sales by Application (2027-2032) & (K Units) Table 141. Asia Satralizumab Sales Price by Application (2021-2026) & (US$/Unit) Table 142. Asia Satralizumab Sales Price by Application (2027-2032) & (US$/Unit) Table 143. Asia Satralizumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Asia Satralizumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 145. Asia Satralizumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 146. Asia Satralizumab Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 147. Asia Satralizumab Sales by Country (2021-2026) & (K Units) Table 148. Asia Satralizumab Sales by Country (2027-2032) & (K Units) Table 149. Asia Satralizumab Sales Price by Country (2021-2026) & (US$/Unit) Table 150. Asia Satralizumab Sales Price by Country (2027-2032) & (US$/Unit) Table 151. Japan Satralizumab Revenue (2021-2032) & (US$ Million) Table 152. South Korea Satralizumab Revenue (2021-2032) & (US$ Million) Table 153. India Satralizumab Revenue (2021-2032) & (US$ Million) Table 154. Australia Satralizumab Revenue (2021-2032) & (US$ Million) Table 155. China Taiwan Satralizumab Revenue (2021-2032) & (US$ Million) Table 156. Southeast Asia Satralizumab Revenue (2021-2032) & (US$ Million) Table 157. SAMEA Satralizumab Revenue by Type (2021-2026) & (US$ Million) Table 158. SAMEA Satralizumab Revenue by Type (2027-2032) & (US$ Million) Table 159. SAMEA Satralizumab Sales by Type (2021-2026) & (K Units) Table 160. SAMEA Satralizumab Sales by Type (2027-2032) & (K Units) Table 161. SAMEA Satralizumab Sales Price by Type (2021-2026) & (US$/Unit) Table 162. SAMEA Satralizumab Sales Price by Type (2027-2032) & (US$/Unit) Table 163. SAMEA Satralizumab Revenue by Application (2021-2026) & (US$ Million) Table 164. SAMEA Satralizumab Revenue by Application (2027-2032) & (US$ Million) Table 165. SAMEA Satralizumab Sales by Application (2021-2026) & (K Units) Table 166. SAMEA Satralizumab Sales by Application (2027-2032) & (K Units) Table 167. SAMEA Satralizumab Sales Price by Application (2021-2026) & (US$/Unit) Table 168. SAMEA Satralizumab Sales Price by Application (2027-2032) & (US$/Unit) Table 169. SAMEA Satralizumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. SAMEA Satralizumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. SAMEA Satralizumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. SAMEA Satralizumab Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 173. SAMEA Satralizumab Sales by Country (2021-2026) & (K Units) Table 174. SAMEA Satralizumab Sales by Country (2027-2032) & (K Units) Table 175. SAMEA Satralizumab Sales Price by Country (2021-2026) & (US$/Unit) Table 176. SAMEA Satralizumab Sales Price by Country (2027-2032) & (US$/Unit) Table 177. Brazil Satralizumab Revenue (2021-2032) & (US$ Million) Table 178. Argentina Satralizumab Revenue (2021-2032) & (US$ Million) Table 179. Chile Satralizumab Revenue (2021-2032) & (US$ Million) Table 180. Colombia Satralizumab Revenue (2021-2032) & (US$ Million) Table 181. Peru Satralizumab Revenue (2021-2032) & (US$ Million) Table 182. Saudi Arabia Satralizumab Revenue (2021-2032) & (US$ Million) Table 183. Israel Satralizumab Revenue (2021-2032) & (US$ Million) Table 184. UAE Satralizumab Revenue (2021-2032) & (US$ Million) Table 185. Turkey Satralizumab Revenue (2021-2032) & (US$ Million) Table 186. Iran Satralizumab Revenue (2021-2032) & (US$ Million) Table 187. Egypt Satralizumab Revenue (2021-2032) & (US$ Million) Table 188. Key Raw Materials Table 189. Raw Materials Key Suppliers Table 190. Satralizumab Distributors List Table 191. Satralizumab Customers List Table 192. Research Programs/Design for This Report Table 193. Authors List of This Report Table 194. Secondary Sources Table 195. Primary Sources List of Figures Figure 1. Satralizumab Image Figure 2. Global Satralizumab Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Satralizumab Market Size Share 2021 VS 2025 VS 2032 Figure 4. Solution Image Figure 5. Injection Image Figure 6. Global Satralizumab Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Satralizumab Market Size Share 2021 VS 2025 VS 2032 Figure 8. Treating Neuromyelitis Optica Image Figure 9. Prevention of Neuromyelitis Optica Image Figure 10. Others Image Figure 11. Global Satralizumab Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Satralizumab Revenue (2021-2032) & (US$ Million) Figure 13. Global Satralizumab Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Satralizumab Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Satralizumab Revenue Market Share by Region (2021-2032) Figure 16. Global Satralizumab Sales (2021-2032) & (K Units) Figure 17. Global Satralizumab Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Satralizumab Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Satralizumab Sales YoY (2021-2032) & (K Units) Figure 20. Europe Satralizumab Sales YoY (2021-2032) & (K Units) Figure 21. China Satralizumab Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Satralizumab Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Satralizumab Sales YoY (2021-2032) & (K Units) Figure 24. Global Satralizumab Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Satralizumab Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Satralizumab Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Satralizumab Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Satralizumab Revenue Market Share by Type (2021-2032) Figure 30. Global Satralizumab Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Satralizumab Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Satralizumab Sales Market Share by Type (2021-2032) Figure 33. Global Satralizumab Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Satralizumab Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Satralizumab Revenue Market Share by Application (2021-2032) Figure 36. Global Satralizumab Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Satralizumab Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Satralizumab Sales Market Share by Application (2021-2032) Figure 39. North America Satralizumab Revenue Share by Type (2021-2032) Figure 40. North America Satralizumab Sales Share by Type (2021-2032) Figure 41. North America Satralizumab Revenue Share by Application (2021-2032) Figure 42. North America Satralizumab Sales Share by Application (2021-2032) Figure 43. North America Satralizumab Revenue Share by Country (2021-2032) Figure 44. North America Satralizumab Sales Share by Country (2021-2032) Figure 45. Europe Satralizumab Revenue Share by Type (2021-2032) Figure 46. Europe Satralizumab Sales Share by Type (2021-2032) Figure 47. Europe Satralizumab Revenue Share by Application (2021-2032) Figure 48. Europe Satralizumab Sales Share by Application (2021-2032) Figure 49. Europe Satralizumab Revenue Share by Country (2021-2032) Figure 50. Europe Satralizumab Sales Share by Country (2021-2032) Figure 51. China Satralizumab Revenue Share by Type (2021-2032) Figure 52. China Satralizumab Sales Share by Type (2021-2032) Figure 53. China Satralizumab Revenue Share by Application (2021-2032) Figure 54. China Satralizumab Sales Share by Application (2021-2032) Figure 55. Asia Satralizumab Revenue Share by Type (2021-2032) Figure 56. Asia Satralizumab Sales Share by Type (2021-2032) Figure 57. Asia Satralizumab Revenue Share by Application (2021-2032) Figure 58. Asia Satralizumab Sales Share by Application (2021-2032) Figure 59. Asia Satralizumab Revenue Share by Country (2021-2032) Figure 60. Asia Satralizumab Sales Share by Country (2021-2032) Figure 61. SAMEA Satralizumab Revenue Share by Type (2021-2032) Figure 62. SAMEA Satralizumab Sales Share by Type (2021-2032) Figure 63. SAMEA Satralizumab Revenue Share by Application (2021-2032) Figure 64. SAMEA Satralizumab Sales Share by Application (2021-2032) Figure 65. SAMEA Satralizumab Revenue Share by Country (2021-2032) Figure 66. SAMEA Satralizumab Sales Share by Country (2021-2032) Figure 67. Satralizumab Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Satralizumab Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Solution
  • Injection
Applications
  • Treating Neuromyelitis Optica
  • Prevention of Neuromyelitis Optica
  • Others
Companies covered
  • Hoffmann La Roche
  • Genentech Inc.
  • CHUGAI PHARMACEUTICAL CO.,LTD.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Satralizumab Market by Type
  3. 1.2.1 Global Satralizumab Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Solution
  5. 1.2.3 Injection
  6. 1.3 Satralizumab Market by Application
  7. 1.3.1 Global Satralizumab Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Treating Neuromyelitis Optica
  9. 1.3.3 Prevention of Neuromyelitis Optica
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Satralizumab Market Dynamics
  1. 2.1 Satralizumab Industry Trends
  2. 2.2 Satralizumab Industry Drivers
  3. 2.3 Satralizumab Industry Opportunities and Challenges
  4. 2.4 Satralizumab Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Satralizumab Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Satralizumab Revenue by Region
  3. 3.2.1 Global Satralizumab Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Satralizumab Revenue by Region (2021-2026)
  5. 3.2.3 Global Satralizumab Revenue by Region (2027-2032)
  6. 3.2.4 Global Satralizumab Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Satralizumab Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Satralizumab Sales by Region
  9. 3.4.1 Global Satralizumab Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Satralizumab Sales by Region (2021-2026)
  11. 3.4.3 Global Satralizumab Sales by Region (2027-2032)
  12. 3.4.4 Global Satralizumab Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Satralizumab Revenue by Manufacturers
  2. 4.1.1 Global Satralizumab Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Satralizumab Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Satralizumab Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Satralizumab Sales by Manufacturers
  6. 4.2.1 Global Satralizumab Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Satralizumab Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Satralizumab Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Satralizumab Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Satralizumab Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Satralizumab Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Satralizumab Manufacturers, Product Type & Application
  13. 4.7 Global Satralizumab Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Satralizumab Market CR5 and HHI
  16. 4.8.2 2025 Satralizumab Tier 1, Tier 2, and Tier 3
5 Satralizumab Market by Type
  1. 5.1 Global Satralizumab Revenue by Type
  2. 5.1.1 Global Satralizumab Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Satralizumab Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Satralizumab Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Satralizumab Sales by Type
  6. 5.2.1 Global Satralizumab Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Satralizumab Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Satralizumab Sales Market Share by Type (2021-2032)
  9. 5.3 Global Satralizumab Price by Type
6 Satralizumab Market by Application
  1. 6.1 Global Satralizumab Revenue by Application
  2. 6.1.1 Global Satralizumab Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Satralizumab Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Satralizumab Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Satralizumab Sales by Application
  6. 6.2.1 Global Satralizumab Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Satralizumab Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Satralizumab Sales Market Share by Application (2021-2032)
  9. 6.3 Global Satralizumab Price by Application
7 Company Profiles
  1. 7.1 Hoffmann La Roche
  2. 7.1.1 Hoffmann La Roche Company Information
  3. 7.1.2 Hoffmann La Roche Business Overview
  4. 7.1.3 Hoffmann La Roche Satralizumab Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Hoffmann La Roche Satralizumab Product Portfolio
  6. 7.1.5 Hoffmann La Roche Recent Developments
  7. 7.2 Genentech Inc.
  8. 7.2.1 Genentech Inc. Company Information
  9. 7.2.2 Genentech Inc. Business Overview
  10. 7.2.3 Genentech Inc. Satralizumab Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Genentech Inc. Satralizumab Product Portfolio
  12. 7.2.5 Genentech Inc. Recent Developments
  13. 7.3 CHUGAI PHARMACEUTICAL CO.,LTD.
  14. 7.3.1 CHUGAI PHARMACEUTICAL CO.,LTD. Company Information
  15. 7.3.2 CHUGAI PHARMACEUTICAL CO.,LTD. Business Overview
  16. 7.3.3 CHUGAI PHARMACEUTICAL CO.,LTD. Satralizumab Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 CHUGAI PHARMACEUTICAL CO.,LTD. Satralizumab Product Portfolio
  18. 7.3.5 CHUGAI PHARMACEUTICAL CO.,LTD. Recent Developments
8 North America
  1. 8.1 North America Satralizumab Market Size by Type
  2. 8.1.1 North America Satralizumab Revenue by Type (2021-2032)
  3. 8.1.2 North America Satralizumab Sales by Type (2021-2032)
  4. 8.1.3 North America Satralizumab Price by Type (2021-2032)
  5. 8.2 North America Satralizumab Market Size by Application
  6. 8.2.1 North America Satralizumab Revenue by Application (2021-2032)
  7. 8.2.2 North America Satralizumab Sales by Application (2021-2032)
  8. 8.2.3 North America Satralizumab Price by Application (2021-2032)
  9. 8.3 North America Satralizumab Market Size by Country
  10. 8.3.1 North America Satralizumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Satralizumab Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Satralizumab Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Satralizumab Market Size by Type
  2. 9.1.1 Europe Satralizumab Revenue by Type (2021-2032)
  3. 9.1.2 Europe Satralizumab Sales by Type (2021-2032)
  4. 9.1.3 Europe Satralizumab Price by Type (2021-2032)
  5. 9.2 Europe Satralizumab Market Size by Application
  6. 9.2.1 Europe Satralizumab Revenue by Application (2021-2032)
  7. 9.2.2 Europe Satralizumab Sales by Application (2021-2032)
  8. 9.2.3 Europe Satralizumab Price by Application (2021-2032)
  9. 9.3 Europe Satralizumab Market Size by Country
  10. 9.3.1 Europe Satralizumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Satralizumab Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Satralizumab Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Satralizumab Market Size by Type
  2. 10.1.1 China Satralizumab Revenue by Type (2021-2032)
  3. 10.1.2 China Satralizumab Sales by Type (2021-2032)
  4. 10.1.3 China Satralizumab Price by Type (2021-2032)
  5. 10.2 China Satralizumab Market Size by Application
  6. 10.2.1 China Satralizumab Revenue by Application (2021-2032)
  7. 10.2.2 China Satralizumab Sales by Application (2021-2032)
  8. 10.2.3 China Satralizumab Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Satralizumab Market Size by Type
  2. 11.1.1 Asia Satralizumab Revenue by Type (2021-2032)
  3. 11.1.2 Asia Satralizumab Sales by Type (2021-2032)
  4. 11.1.3 Asia Satralizumab Price by Type (2021-2032)
  5. 11.2 Asia Satralizumab Market Size by Application
  6. 11.2.1 Asia Satralizumab Revenue by Application (2021-2032)
  7. 11.2.2 Asia Satralizumab Sales by Application (2021-2032)
  8. 11.2.3 Asia Satralizumab Price by Application (2021-2032)
  9. 11.3 Asia Satralizumab Market Size by Country
  10. 11.3.1 Asia Satralizumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Satralizumab Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Satralizumab Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Satralizumab Market Size by Type
  2. 12.1.1 SAMEA Satralizumab Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Satralizumab Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Satralizumab Price by Type (2021-2032)
  5. 12.2 SAMEA Satralizumab Market Size by Application
  6. 12.2.1 SAMEA Satralizumab Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Satralizumab Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Satralizumab Price by Application (2021-2032)
  9. 12.3 SAMEA Satralizumab Market Size by Country
  10. 12.3.1 SAMEA Satralizumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Satralizumab Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Satralizumab Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Satralizumab Value Chain Analysis
  2. 13.1.1 Satralizumab Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Satralizumab Production Mode & Process
  6. 13.2 Satralizumab Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Satralizumab Distributors
  9. 13.2.3 Satralizumab Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst